SEC 13F Intelligence

Ecor1 Capital, LLC / JANX

Ecor1 Capital, LLC’s Janux Therapeutics Inc Position

Does Ecor1 Capital, LLC own Janux Therapeutics Inc (JANX)? Not currently — the last reported position was 1.47M shares worth $34M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$34M
Q2 2025
Shares
1.47M
% of Portfolio
+2.01%
Quarters Held
14
position exited

Position History JANX

Reported value by quarter
Q2 ’21: $35MQ2 ’21Q3 ’21: $31MQ4 ’21: $28MQ4 ’21Q1 ’22: $20MQ2 ’22: $17MQ2 ’22Q3 ’22: $19MQ4 ’22: $19MQ4 ’22Q1 ’23: $46MQ2 ’23: $5MQ2 ’23Q2 ’24: $62MQ3 ’24: $67MQ3 ’24Q4 ’24: $79MQ1 ’25: $40MQ1 ’25Q2 ’25: $34Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 20251.47M$34M+2.01%
Q1 20251.47M$40M+2.35%
Q4 20241.47M$79M+2.98%
Q3 20241.47M$67M+2.29%
Q2 20241.47M$62M+1.88%
Q2 2023452.6K$5M+0.13%
Q1 20233.84M$46M+1.50%
Q4 20221.42M$19M+0.57%
Q3 20221.42M$19M+0.57%
Q2 20221.42M$17M+0.60%
Q1 20221.42M$20M+0.64%
Q4 20211.41M$28M+0.89%
Q3 20211.41M$31M+1.06%
Q2 20211.41M$35M+1.32%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ecor1 Capital, LLC’s full portfolio or all institutional holders of JANX.